Close Menu

NEW YORK – 3M and researchers from Massachusetts Institute of Technology announced Tuesday they are developing a rapid antigen diagnostic test for SARS-CoV-2.

The US National Institute of Health chose the test for accelerated development and commercialization support under its Rapid Acceleration of Diagnostics Tech program for "aggressively-paced COVID-19 diagnostics," 3M and the researchers said in a statement. The project received $500,00 from the program and is eligible for further investment as development continues.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.